Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Asthma among children in Europe
Journal Information
Vol. 32. Issue 3.
Pages 100 (May 2004)
Share
Share
Download PDF
More article options
Vol. 32. Issue 3.
Pages 100 (May 2004)
Full text access
Asthma among children in Europe
Visits
2746
SK. Weilanda
a Department of Epidemiology, University of Ulm, Ulm, Germany
This item has received
Article information
Full Text

International comparative studies investigating variation in disease prevalence between populations and their determinants have made important contributions to the understanding of disease aetiology in many areas. Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) used standardised questionnaires and found marked differences in the prevalence of asthma symptoms in 13-14 year olds and 6-7 year olds living in 55 different study centres in Europe. The prevalence of wheeze in the last 12 months ranged from 2.6-32.2 % in the older age group and 3.5-18.4 % in the younger age group. It was particularly high in the English speaking countries (Ireland and UK) and low in Albania, Georgia, Greece and Spain. Factors which have been found to influence the variation include nutrition, hygiene and climate. Phase II of ISAAC aimed to investigate these differences further using physiological measurements and to identify determinants of the observed differences in informative populations. A detailed study protocol was developed for use in community based random samples of 9-11 year old children (1000 per centre). The study modules include standardised questionnaires and protocols for examination of flexural dermatitis, skin prick testing, bronchial challenge with hypertonic saline, blood sampling for IgE analyses and genotyping, and dust sampling for assessment of indoor exposures to allergens and endotoxin. ISAAC II field work has been completed or started in 19 study centres in Europe, including four in Spain. The majority of centers is from countries which participated in ISAAC Phase I and reflect almost the full range of the observed variability in phase I prevalence rates. The data provide a framework for studies of populations in contrasting environments which are expected to yield new clues about the aetiology of asthma.

Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos